Startsida. RED BOOK - Thomson Reuters. Current, comprehensive, and accurate drug pricing information is difficult to find. As part of the Thomson Reuters suite of products, RED BOOK™ is the essential resource healthcare professionals reach for every day to find the latest information on Rx and OTC products. RED BOOK reduces the need to conduct redundant searches and simplifies identification, analysis, and comparison of drug and non-drug products. And you can take advantage of RED BOOK's convenience through multiple delivery options. As drug reimbursement benchmarks are developed, Thomson Reuters and RED BOOK will continue to deliver transparent and consistent drug pricing information.
"As a Medical PBM, NovoLogix provides technologies and systems to some of the nation's leading health plans, and integral to that is having a trusted source of drug information. VIDAL | L'information de référence sur les produits de santé. BNF.org. Aktuelles - GELBE LISTE PHARMINDEX Online.